ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 120 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $313,212 | 0.0% | 108,004 | 0.0% | 0.00% | – |
| Q1 2023 | $313,212 | -99.9% | 108,004 | +32.5% | 0.00% | – |
| Q3 2022 | $308,157,000 | -51.5% | 81,523 | 0.0% | 0.00% | – |
| Q2 2022 | $635,064,000 | -16.1% | 81,523 | 0.0% | 0.00% | – |
| Q1 2022 | $757,350,000 | -34.4% | 81,523 | +11.3% | 0.00% | – |
| Q4 2021 | $1,154,609,000 | -11.9% | 73,262 | +0.1% | 0.00% | -100.0% |
| Q3 2021 | $1,310,441,000 | -2.1% | 73,209 | -15.0% | 0.00% | 0.0% |
| Q2 2021 | $1,339,042,000 | +15.4% | 86,112 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $1,160,546,000 | -26.8% | 80,818 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,586,457,000 | +102.4% | 80,818 | +33.6% | 0.00% | – |
| Q3 2020 | $783,859,000 | -17.5% | 60,483 | -7.2% | 0.00% | -100.0% |
| Q2 2020 | $949,643,000 | +88.6% | 65,178 | +10.2% | 0.00% | – |
| Q1 2020 | $503,476,000 | -32.1% | 59,163 | +31.4% | 0.00% | – |
| Q4 2019 | $741,299,000 | -85.3% | 45,009 | -87.4% | 0.00% | -100.0% |
| Q3 2019 | $5,052,842,000 | -6.2% | 357,850 | +33.6% | 0.00% | -25.0% |
| Q2 2019 | $5,384,915,000 | -40.3% | 267,773 | +18.0% | 0.00% | -42.9% |
| Q1 2019 | $9,022,336,000 | +14.9% | 226,977 | +0.4% | 0.01% | 0.0% |
| Q4 2018 | $7,853,915,000 | -12.6% | 226,077 | +4.0% | 0.01% | 0.0% |
| Q3 2018 | $8,990,235,000 | +5.1% | 217,418 | -6.5% | 0.01% | 0.0% |
| Q2 2018 | $8,550,109,000 | +1333.5% | 232,656 | +1421.2% | 0.01% | – |
| Q1 2018 | $596,466,000 | +8740.5% | 15,294 | -96.8% | 0.00% | -100.0% |
| Q4 2016 | $6,747,000 | -63.0% | 475,172 | -44.3% | 0.01% | -60.0% |
| Q3 2016 | $18,241,000 | -29.7% | 852,815 | -26.0% | 0.02% | -31.0% |
| Q2 2016 | $25,947,000 | +12.2% | 1,152,663 | -5.2% | 0.03% | +7.4% |
| Q1 2016 | $23,133,000 | -29.1% | 1,215,653 | -1.6% | 0.03% | -27.0% |
| Q4 2015 | $32,628,000 | -6.1% | 1,235,435 | +11.7% | 0.04% | -2.6% |
| Q3 2015 | $34,759,000 | +6.3% | 1,105,558 | +78.5% | 0.04% | +22.6% |
| Q2 2015 | $32,685,000 | +410.1% | 619,509 | +302.0% | 0.03% | +416.7% |
| Q1 2015 | $6,407,000 | +317.9% | 154,124 | +168.9% | 0.01% | +500.0% |
| Q4 2014 | $1,533,000 | – | 57,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |